Bingliang Chen

机构：Sun Yat-sen University, Guangdong Province Stomatological Hospital, Sun Yat-sen Memorial Hospital, First Affiliated Hospital of Chengdu Medical College, Guangdong Provincial Center for Disease Control and Prevention, Tongji Hospital, Innovent Biologics (China), Huazhong University of Science and Technology · ORCID：0009-0008-0757-7722

发表论文 103 篇 · 总被引 1717 次 · h-index 20

代表论文

• IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells (2023 · Nature Cancer · 被引 80)
• Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis (2023 · Advanced Science · 被引 55)
• CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma (2023 · Cellular Signalling · 被引 31)
• MiRNA‐100 ameliorates diabetes mellitus‐induced erectile dysfunction by modulating autophagy, anti‐inflammatory, and antifibrotic effects (2024 · Andrology · 被引 18)
• Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer – an in-depth quantitative evaluation and retrospective cohort analysis (2024 · International Journal of Surgery · 被引 13)
• An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer (2025 · Journal of Translational Medicine · 被引 10)